ABSTRACT
Background Physical performance tests are predictive of mortality and have been proposed for screening for certain health conditions (e.g., sarcopenia); however, the diagnostic screening and prognostic value of physical performance tests has primarily been studied in age-limited or disease-specific cohorts. In this study, we sought to identify the most salient characteristics associated with three lower quarter balance and strength tests in a deeply phenotyped cohort of community-dwelling adults.
Methods We applied a stacked elastic net approach on detailed data on sociodemographic, health and health-related behaviors, and biomarker data from the first visit of the Project Baseline Health Study (N=2502) to determine which variables were most associated with three physical performance measures: single-legged balance test (SLBT), sitting-rising test (SRT), and 30-second chair-stand test (30CST). Analyses were stratified by age (<65 and ≥65).
Results Female sex, Black or African American race, lower educational attainment, and health conditions such as non-alcoholic fatty liver disease and cardiovascular conditions (e.g., hypertension) were consistently associated with worse performance across all three tests. Several other health conditions were associated with either better or worse test performance, depending on age group and test. C-reactive protein was the only laboratory value associated with performance across age and test groups with some consistency.
Conclusions Our results highlighted previously identified and several novel salient factors associated with performance on the SLBT, SRT, and 30CST. Future research should discern and validate the value of these tests as affordable, noninvasive biomarkers of prevalent and/or future disease in the community.
Competing Interest Statement
The Project Baseline Health Study and this analysis are funded by Verily Life Sciences, San Francisco, CA. This analysis was funded by Verily Life Sciences (San Francisco, CA) in partnership with Stanford University and Duke University. The employees from the funding source contributed to the data analyses, interpretation, editing of the manuscript and are coauthors. The final decision to submit the manuscript was made by the academic authors.
Funding Statement
The Project Baseline Health Study and this analysis are funded by Verily Life Sciences, San Francisco, CA.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The PBHS is a multicenter longitudinal cohort study of adults in the United States (ClinicalTrials.gov identifier NCT03154346), approved by both a central Institutional Review Board (the WCG IRB; approval tracking number 20170163, work order number 1-1506365-1) and IRBs at each of the participating institutions: Stanford University (Palo Alto, CA), Duke University (Durham, NC; Kannapolis, NC), and the California Health and Longevity Institute (CHLI; Los Angeles, CA).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
# Funding Sources: The Project Baseline Health Study and this analysis are funded by Verily Life Sciences, San Francisco, CA. This analysis was funded by Verily Life Sciences (San Francisco, CA) in partnership with Stanford University and Duke University. The employees from the funding source contributed to the data analyses, interpretation, editing of the manuscript and are coauthors. The final decision to submit the manuscript was made by the academic authors.
Data Availability
The deidentified PBHS data corresponding to this study are available upon request for the purpose of examining its reproducibility. Interested investigators should direct requests to jsaiz{at}verily.com. Requests are subject to approval by PBHS governance.
